# Evommune, Inc.: Form 8-K, filed Nov 7, 2025

- Company: [Evommune, Inc.](/companies/evmn.md) (CIK 2044725)
- Form: 8-K
- Filed: 2025-11-07
- Accepted by EDGAR: Nov 7, 2025, 16:01 ET
- Period: 2025-11-07
- Accession: 0001193125-25-272282
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/d38367d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2044725/000119312525272282/d38367d8k.htm

Filed Nov 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-272282. Last ingested by Listed: Nov 11, 2026, 02:25 ET. No prices; not investment advice.